Controlled Attenuation Parameter and Gallstone Disease Risk: A Retrospective Cohort Study with Mediation Analysis and Longitudinal Trajectory Modeling, Emphasizing Gender-Specific Effects

受控衰减参数与胆结石疾病风险:一项回顾性队列研究,采用中介分析和纵向轨迹模型,重点关注性别差异效应

阅读:2

Abstract

BACKGROUND: The association between the controlled attenuation parameter (CAP)-a noninvasive marker for hepatic steatosis-and gallstone disease (GSD) remains poorly understood. This study aimed to investigate the impact of CAP levels and their longitudinal trajectories on GSD risk and explore potential mediating pathways. METHODS: A dynamic cohort of 6,308 adults without baseline GSD underwent serial health examinations in Ya'an, China, from January 2020 to April 2025. The statistical methods included multivariate Cox regression analysis, restricted cubic spline (RCS) analysis, and mediation analysis. For sensitivity analyses, we performed gender-stratified analysis, trial sequential analysis (TSA), cumulative risk curve plotting, and re-analysis after excluding individuals with baseline diseases. Among 412 participants with ≥ 3 CAP measurements, group-based trajectory modelling (GBTM) identified CAP patterns and related them to GSD incidence. RESULTS: Each 1-SD increase in CAP was associated with a 40% higher GSD risk, with a stronger association in women (HR = 1.96, P = 0.02) than in men (HR = 1.36, P = 0.04). RCS revealed a strictly linear dose-response relationship between CAP and GSD risk (P (non-linear) = 0.43). Compared with the reference group (CAP ≤ 238 dB/m), moderate (259-292 dB/m) and severe (> 292 dB/m) steatosis were associated with significantly higher GSD risk (HR = 2.56, P < 0.01; HR = 2.47, P = 0.01, respectively), whereas mild steatosis (238-259 dB/m) showed no significant association (P = 0.11). GBTM identified "persistently low" (61.41%) and "persistently high" (38.59%) CAP trajectories, with the latter group having a 3.85-fold higher GSD risk (P = 0.04). Mediation analysis identified a significant pathway from CAP to GSD via high-density lipoprotein cholesterol (HDL-C, P < 0.01, proportion of mediation = 27.49%). CONCLUSION: CAP is positively and linearly associated with GSD risk, particularly in women. Persistently high CAP levels confer a significantly elevated GSD risk. HDL-C is a significant mediator.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。